GOLDBELT FALCON LLC

Goldbelt Falcon LLC specializes in biotechnology research and development support services, with a focused expertise in laboratory operations, chemical analysis, and scientific research coordination for federal health agencies. Their work centers on supporting IGF chemist functions and broader R&D initiatives, demonstrating proficiency in assay development, biochemical testing protocols, and data-driven research execution within regulated environments. The contractor’s technical capabilities include precision laboratory instrumentation, compliance with Good Laboratory Practices (GLP), and end-to-end support for biomedical research pipelines, positioning them as a reliable partner for mission-critical scientific endeavors requiring methodological rigor and regulatory alignment. The company has established a consistent relationship with the Department of Health and Human Services, delivering specialized research support services that underpin public health initiatives. Their engagements involve direct scientific staffing and operational assistance in biotechnology labs, suggesting deep familiarity with HHS program objectives, particularly those related to endocrine research and therapeutic development. This pattern indicates a trusted, repeat partnership built on consistent delivery of technical expertise in high-stakes health research settings. Goldbelt Falcon’s primary industry focus is in NAICS 541711—research and development in biotechnology—where they operate at the intersection of analytical chemistry and applied biomedical science. Their market positioning is niche but strategic, serving federal clients requiring highly specialized scientific personnel and research infrastructure support rather than broad-spectrum contract research. They are not positioned as a large-scale R&D firm but as a precision provider of technical labor and scientific coordination services. As a small business structured as a 2L entity based in Chesapeake, Virginia, Goldbelt Falcon LLC maintains a lean, agile operational model. While currently holding no formal government certifications, their geographic proximity to federal health research hubs and demonstrated track record in HHS-supported projects reinforce their credibility within the federal biotech services market.